Glomerular Filtration Rate (GFR) Reporting on Nephrology Referral Patterns by Internists

Chronic Kidney Disease Clinical Trial

Official title:

The Effect of MDRD GFR Reporting on Nephrology Referral Patterns by Internists

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT00134797
• Other study ID #: CIP #S-04-058
• Status: Recruiting
• Phase: N/A
• First received: August 24, 2005
• Last updated: November 4, 2005
• Start date: February 2005
• Est. completion date: February 2006

Study information

• Verified date: August 2005
• Source: United States Naval Medical Center, San Diego
• Contact: Heather J Miller, M.D.
• Email: HJMiller1[@]nmcsd.med.navy.mil
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Observational

Clinical Trial Summary

The addition of an estimate value of glomerular filtration rate (GFR) per Modification of Diet in Renal Disease [MDRD] (LEVEY) equation is being included and reported on all routine chemistry panels in the experimental group. The control group is only having serum creatinine, the current standard of care, reported on routine chemistry panels.

Description:

All patients already referred to or being followed by nephrologists were excluded. Inclusion criteria were all patients in the Internal Medicine clinic at NMCSD who were sent to the lab to obtain routine chemistry panels for follow up by their primary care providers. The primary outcome is increased referral to nephrology in accordance with NKF K/DOQI guidelines if GFR values are reported on routine chemistry panels. Key secondary outcomes are Primary Care Provider knowledge of NKF K/DOQI guidelines, specifically when patients with chronic kidney disease need to be referred to a nephrologist for further evaluation.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 1500
• Est. completion date: February 2006
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patients in the Internal Medicine Clinic at Naval Medical Center, San Diego (NMCSD) who were sent to the lab to obtain follow up by their primary care providers.

Exclusion Criteria:

• All patients referred to or being followed by nephrologists.

Study Design

Observational Model: Defined Population, Primary Purpose: Screening, Time Perspective: Longitudinal

Related Conditions & MeSH terms

• Chronic Kidney Disease
• Kidney Diseases
• Renal Insufficiency, Chronic

Locations

Country	Name	City	State
United States	Naval Medical Center San Diego	San Diego	California

Sponsors (1)

Lead Sponsor	Collaborator
United States Naval Medical Center, San Diego

Country where clinical trial is conducted

United States,